[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.247.205. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Note
Aug 2011

Propranolol Therapy for Hemorrhagic Lymphangioma of the Tongue

Author Affiliations

Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Drs Leboulanger, Garabedian, and Denoyelle), Radiology (Dr Garel), and Cardiology (Dr Borde), Armand Trousseau Children's Hospital, Paris, France.

Arch Otolaryngol Head Neck Surg. 2011;137(8):813-815. doi:10.1001/archoto.2011.70

Lingual localization of lymphangiomas presents a therapeutic challenge mostly because of the lesions' microcystic characteristics, which make complete surgical excision difficult if not impossible, and because of the functional problems they cause (obstruction, pain, feeding problems, edema, jaw deformities, breathing problems, and bleeding). Partial glossectomies have a high rate of relapse and can result in morphological changes in the tongue; sclerosing agents cannot be used on microcystic lesions. The use of several treatments aiming to resurface microcystic lymphatic lingual lesions with hemorrhagic vesicles, including laser and radiofrequency resurfacing (Coblation [cold plus ablation]; ArthroCare ENT, Austin, Texas), has been reported, sometimes with good results.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×